Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fitbits track recovery after bladder surgery to prevent hospital returns

NCT ID NCT07148765

First seen Nov 01, 2025 · Last updated Jun 24, 2026 · Updated 33 times

Summary

This study looks at whether wearing a Fitbit and answering daily smartphone questions can help doctors spot early signs of trouble in patients recovering from bladder removal surgery. Fifty adults scheduled for cystectomy will wear the device before and after surgery. If the Fitbit or survey shows worrying changes, a healthcare provider will check in within 24 hours. The goal is to see if this approach is practical and can predict complications that might lead to readmission.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • UPMC

    Pittsburgh, Pennsylvania, 15232, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Fitbit Sense 2 wearable device and smartphone survey

What this could lead to

If successful, this could show that wearable devices help doctors detect complications early after bladder surgery, potentially reducing readmissions.

What could go wrong

This is a small, early feasibility study with only 50 participants, so results may not apply to everyone. The technology may not reliably predict complications.

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms Urinary Bladder, Neurogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.